Similarly, Degan et al. confirmed that these IGHV ongoing mutations found in CLL bore the signature of AID, and were compatible with reparation mechanisms involving both AID and error-prone bypass lesion DNA polymerases [10, 13]. Here, AICDA is linked to B-cell chronic lymphocytic leukemia.